HIRSCHMAN ORIN 13D/13G Filings for Context Therapeutics Inc. (CNTX)

HIRSCHMAN ORIN 13D and 13G filings for Context Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-01-09
5:05 pm
Sale		 2023-01-09 13G Context Therapeutics Inc.
CNTX		 HIRSCHMAN ORIN 0
0.000%		 -1,285,771decrease
(Position Closed)		 Filing
2022-10-27
1:22 pm
Purchase		 2022-01-06 13G Context Therapeutics Inc.
CNTX		 HIRSCHMAN ORIN 1,285,771
8.100%		 1,285,771increase
(New Position)		 Filing